Home > Courses > Toward a Cure for HIV: Are We There Yet?

Toward a Cure for HIV: Are We There Yet?

Toward a Cure for HIV: Are We There Yet?
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 11/16/2010
Review Date: 11/16/2010
  • Tae-Wook Chun, PhD
    Associate Scientist
    National Institute of Allergy and Infectious Diseases
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand the evolution of HIV reservoir research.
  2. Explain the impact of antiretroviral therapy on HIV reservoirs.
  3. Discuss the mechanisms of HIV persistence in infected individuals receiving antiretroviral therapy.
  4. Examine the feasibility of eradication of HIV in infected individuals receiving antiretroviral therapy.
Presenter Bio
Tae-Wook Chun, PhD
Tae-Wook Chun received his PhD in Biochemistry, Cellular, and Molecular Biology from Johns Hopkins University School of Medicine. In 1997, he identified and characterized latently infected, resting CD4+ T cells in HIV-infected individuals. He then pursued postdoctoral work at the NIH, where he demonstrated that latent HIV reservoir persists in virtually all infected individuals receiving antiretroviral therapy despite effective suppression of plasma viremia, and that early initiation of antiretroviral therapy leads to a decay of the latent viral reservoir. He is currently an Associate Scientist at the NIH and continues to study the role of viral reservoirs in the pathogenesis of HIV disease and is working towards developing therapeutic strategies aimed at achieving sustained virologic remission in infected individuals without antiretroviral therapy.
PRN Learning Modules